<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Eur J Hum Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Eur. J. Hum. Genet</journal-id>
<journal-title-group>
<journal-title>European Journal of Human Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1018-4813</issn>
<issn pub-type="epub">1476-5438</issn>
<publisher>
<publisher-name>Nature Publishing Group</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27966542</article-id>
<article-id pub-id-type="pmc">5255945</article-id>
<article-id pub-id-type="pii">ejhg2016145</article-id>
<article-id pub-id-type="doi">10.1038/ejhg.2016.145</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Epilepsy-causing sequence variations in <italic>SIK1</italic> disrupt synaptic activity response gene expression and affect neuronal morphology</article-title>
<alt-title alt-title-type="running">SIK1 neuronal studies</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Pröschel</surname>
<given-names>Christoph</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hansen</surname>
<given-names>Jeanne N</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ali</surname>
<given-names>Adil</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tuttle</surname>
<given-names>Emily</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lacagnina</surname>
<given-names>Michelle</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Buscaglia</surname>
<given-names>Georgia</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Halterman</surname>
<given-names>Marc W</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Paciorkowski</surname>
<given-names>Alex R</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff4">4</xref>
<xref ref-type="corresp" rid="caf1">*</xref>
</contrib>
<aff id="aff1"><label>1</label><institution>Department of Biomedical Genetics, University of Rochester Medical Center</institution>, Rochester, NY, <country>USA</country></aff>
<aff id="aff2"><label>2</label><institution>Department of Pediatrics, University of Rochester Medical Center</institution>, Rochester, NY, <country>USA</country></aff>
<aff id="aff3"><label>3</label><institution>Center for Neural Development and Disease, University of Rochester Medical Center</institution>, Rochester, NY, <country>USA</country></aff>
<aff id="aff4"><label>4</label><institution>Departments of Neurology and Neuroscience, University of Rochester Medical Center</institution>, Rochester, NY, <country>USA</country></aff>
</contrib-group>
<author-notes>
<corresp id="caf1"><label>*</label><institution>Department of Child Neurology, University of Rochester Medical Center</institution>, 601 Elmwood Avenue, Rochester, NY 14642, <country>USA</country>. Tel: +1 585 275 2808; Fax: +1 585 275 3683; E-mail: <email>Alex_Paciorkowski@urmc.rochester.edu</email></corresp>
<fn fn-type="COI-statement">
<p>The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<month>02</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>14</day>
<month>12</month>
<year>2016</year>
</pub-date>
<volume>25</volume>
<issue>2</issue>
<fpage>216</fpage>
<lpage>221</lpage>
<history>
<date date-type="received">
<day>07</day>
<month>03</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>20</day>
<month>09</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>09</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017 Macmillan Publishers Limited, part of Springer Nature.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Macmillan Publishers Limited, part of Springer Nature.</copyright-holder>
</permissions>
<abstract>
<p><italic>SIK1</italic> syndrome is a newly described developmental epilepsy disorder caused by heterozygous mutations in the salt-inducible kinase <italic>SIK1.</italic> To better understand the pathophysiology of <italic>SIK1</italic> syndrome, we studied the effects of <italic>SIK1</italic> pathogenic sequence variations in human neurons. Primary human fetal cortical neurons were transfected with a lentiviral vector to overexpress wild-type and mutant SIK1 protein. We evaluated the transcriptional activity of known downstream gene targets in neurons expressing mutant SIK1 compared with wild type. We then assayed neuronal morphology by measuring neurite length, number and branching. Truncating <italic>SIK1</italic> sequence variations were associated with abnormal MEF2C transcriptional activity and decreased MEF2C protein levels. Epilepsy-causing <italic>SIK1</italic> sequence variations were associated with significantly decreased expression of <italic>ARC</italic> (activity-regulated cytoskeletal-associated) and other synaptic activity response element genes. Assay of mRNA levels for other <italic>MEF2C</italic> target genes <italic>NR4A1</italic> (<italic>Nur77</italic>) and <italic>NRG1</italic>, found significantly, decreased the expression of these genes as well. The missense p.(Pro287Thr) <italic>SIK1</italic> sequence variation was associated with abnormal neuronal morphology, with significant decreases in mean neurite length, mean number of neurites and a significant increase in proximal branches compared with wild type. Epilepsy-causing <italic>SIK1</italic> sequence variations resulted in abnormalities in the <italic>MEF2C-ARC</italic> pathway of neuronal development and synapse activity response. This work provides the first insights into the mechanisms of pathogenesis in <italic>SIK1</italic> syndrome, and extends the <italic>ARX-MEF2C</italic> pathway in the pathogenesis of developmental epilepsy.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>